🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis

Recruitingn/aAges 18 Years - anyAllChinese University of Hong Kong
NCT05688865 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To assess the correlation of these urinary biomarkers with the serum sample and evaluated the clinical utility of using urinary sample in the detection and prognostication of MGN. Fifty patients with newly diagnosed biopsy proven MGN would be recruited and followed up for 1 years. Serum and urinary biomarkers would be collected every 4 months and their antibody titres measured with ELISA assay.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * newly diagnosed biopsy proven primary membranous glomerulonephritis Exclusion Criteria: * secondary causes of membranous nephropathy, e.g. lupus nephritis, viral hepatitis B and C and malignancy
💊

What it tests

  • urinary markers
📍

Where

1 site
Department of Medicine & Therapeutics, Prince of Wales Hospital
Shatin, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy